Advertisement
Screener

FTI CONSULTING, INC (FCN) Net Income (Loss) Available to Common Stockholders, Diluted

2.5 / 5 stars · 61/120 Roast Me

FTI CONSULTING, INC Net Income (Loss) Available to Common Stockholders, Diluted

FTI CONSULTING, INC (FCN) reported Net Income (Loss) Available to Common Stockholders, Diluted of $57.81 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-07-30

  • FTI CONSULTING, INC net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was $57.81M, a 19.37% decline year-over-year.
  • FTI CONSULTING, INC net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was $57.63M, a 6.78% decline year-over-year.
  • FTI CONSULTING, INC net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was $54.53M, a 9.70% increase year-over-year.
  • FTI CONSULTING, INC net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $82.82M, a 24.60% increase year-over-year.
  • FTI CONSULTING, INC net income (loss) available to common stockholders, diluted for fiscal 2025 was $270.87M, a 3.29% decline from fiscal 2024.
  • FTI CONSULTING, INC net income (loss) available to common stockholders, diluted for fiscal 2024 was $280.09M, a 1.89% increase from fiscal 2023.
  • FTI CONSULTING, INC net income (loss) available to common stockholders, diluted for fiscal 2023 was $274.89M, a 16.72% increase from fiscal 2022.
  • FTI CONSULTING, INC net income (loss) available to common stockholders, diluted for fiscal 2022 was $235.51M, a 0.23% increase from fiscal 2021.
Period endNet Income (Loss) Available to Common Stockholders, Diluted 3 monthNet Income (Loss) Available to Common Stockholders, Diluted 6 monthNet Income (Loss) Available to Common Stockholders, Diluted 9 monthNet Income (Loss) Available to Common Stockholders, Diluted 12 month
2026-06-30$57.81M
10-Q · filed 2026-07-30
$115.44M
10-Q · filed 2026-07-30
$169.97M
derived: sum of 3 quarters · filed 2026-07-30
$252.79M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$57.63M
10-Q · filed 2026-04-30
$112.16M
derived: sum of 2 quarters · filed 2026-04-30
$194.98M
derived: sum of 3 quarters · filed 2026-04-30
$266.68M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$54.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$137.35M
derived: sum of 2 quarters · filed 2026-02-26
$209.05M
derived: sum of 3 quarters · filed 2026-07-30
$270.87M
10-K · filed 2026-02-26
2025-09-30$82.82M
10-Q · filed 2025-10-23
$154.52M
derived: sum of 2 quarters · filed 2026-07-30
$216.34M
10-Q · filed 2025-10-23
$266.05M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$71.70M
10-Q · filed 2026-07-30
$133.52M
10-Q · filed 2026-07-30
$183.23M
derived: sum of 3 quarters · filed 2026-07-30
$249.70M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$61.82M
10-Q · filed 2026-04-30
$111.53M
derived: sum of 2 quarters · filed 2026-04-30
$178.00M
derived: sum of 3 quarters · filed 2026-04-30
$261.95M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$49.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$116.18M
derived: sum of 2 quarters · filed 2026-02-26
$200.12M
derived: sum of 3 quarters · filed 2026-02-26
$280.09M
10-K · filed 2026-02-26
2024-09-30$66.47M
10-Q · filed 2025-10-23
$150.41M
derived: sum of 2 quarters · filed 2025-10-23
$230.38M
10-Q · filed 2025-10-23
$312.01M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$83.95M
10-Q · filed 2025-07-24
$163.91M
10-Q · filed 2025-07-24
$245.54M
derived: sum of 3 quarters · filed 2026-02-26
$328.86M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$79.97M
10-Q · filed 2025-04-24
$161.60M
derived: sum of 2 quarters · filed 2026-02-26
$244.91M
derived: sum of 3 quarters · filed 2026-02-26
$307.31M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$81.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$164.95M
derived: sum of 2 quarters · filed 2026-02-26
$227.34M
derived: sum of 3 quarters · filed 2026-02-26
$274.89M
10-K · filed 2026-02-26
2023-09-30$83.32M
10-Q · filed 2024-10-24
$145.71M
derived: sum of 2 quarters · filed 2024-10-24
$193.26M
10-Q · filed 2024-10-24
$240.76M
derived: sum of 4 quarters · filed 2025-02-20
2023-06-30$62.40M
10-Q · filed 2024-07-25
$109.94M
10-Q · filed 2024-07-25
$157.44M
derived: sum of 3 quarters · filed 2025-02-20
$234.71M
derived: sum of 4 quarters · filed 2025-02-20
2023-03-31$47.55M
10-Q · filed 2024-04-25
$95.05M
derived: sum of 2 quarters · filed 2025-02-20
$172.31M
derived: sum of 3 quarters · filed 2025-02-20
$223.74M
derived: sum of 4 quarters · filed 2025-02-20
2022-12-31$47.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
$124.77M
derived: sum of 2 quarters · filed 2025-02-20
$176.19M
derived: sum of 3 quarters · filed 2025-02-20
$235.51M
10-K · filed 2025-02-20
2022-09-30$77.27M
10-Q · filed 2023-10-26
$128.69M
derived: sum of 2 quarters · filed 2023-10-26
$188.02M
10-Q · filed 2023-10-26
$226.22M
derived: sum of 4 quarters · filed 2024-02-22
2022-06-30$51.43M
10-Q · filed 2023-07-27
$110.75M
10-Q · filed 2023-07-27
$148.96M
derived: sum of 3 quarters · filed 2024-02-22
$218.44M
derived: sum of 4 quarters · filed 2024-02-22
2022-03-31$59.32M
10-Q · filed 2023-04-27
$97.53M
derived: sum of 2 quarters · filed 2024-02-22
$167.01M
derived: sum of 3 quarters · filed 2024-02-22
$229.79M
derived: sum of 4 quarters · filed 2024-02-22
2021-12-31$38.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22
$107.69M
derived: sum of 2 quarters · filed 2024-02-22
$170.47M
derived: sum of 3 quarters · filed 2024-02-22
$234.97M
10-K · filed 2024-02-22
2021-09-30$69.48M
10-Q · filed 2022-10-27
$132.26M
derived: sum of 2 quarters · filed 2022-10-27
$196.76M
10-Q · filed 2022-10-27
2021-06-30$62.78M
10-Q · filed 2022-07-28
$127.28M
10-Q · filed 2022-07-28
2020-12-31$210.68M
10-K · filed 2023-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
EXPONENT INC (EXPO)United States$3.065B26.46
Huron Consulting Group Inc. (HURN)United States$2.557B20.80
Astrana Health, Inc. (ASTH)United States$1.921B63.77
Genpact LTD (G)$5.608B7.94
ICF International, Inc. (ICFI)United States$1.490B14.74
Bowman Consulting Group Ltd. (BWMN)United States$0.738B68.09
Onterris, Inc. (ONT)United States$0.590B-63.69
Public Policy Holding Company, Inc. (PPHC)United States$0.347B
Aeries Technology, Inc. (AERT)Cayman Islands$0.336B-0.00
TSS, Inc. (TSSI)United States$0.288B24.06